Steven Xu

Steven Xu is a highly experienced professional in the field of Clinical Pharmacology and Quantitative Science, currently serving as Senior Director at Genmab since July 2019. Prior to this role, Steven held various positions at Johnson & Johnson from December 2006 to July 2019, including Director, Associate Director, and Senior Scientist, all focused on Clinical Pharmacology and Pharmacometrics. Earlier career experience includes serving as a Research Investigator at Bristol-Myers Squibb and a Research Fellow at the Rutgers Cancer Institute of New Jersey. Steven holds a Ph.D. in Public Health and a Master's degree in Statistics from Rutgers University–New Brunswick, in addition to a Master's degree from Nanjing University.